On April 7th, BEKE-W (02423) spent 7 million US dollars to repurchase 1.3948 million shares.

18:09 08/04/2026

Bekele Inc. (02423) announced that the company repurchased 1.3948 million shares on April 7, 2026, at a cost of $7 million, with a repurchase price of $4.97-5.07 per share.

BEKE-W (02423) announced on April 7, 2026 that the company will spend $7 million to repurchase 1.3948 million shares at a repurchase price of $4.97-5.07 per share.

Pagoda GP spent around HK$4.6894 million to repurchase 2.5 million shares on April 8th.

Ze Jing Pharmaceuticals (688266.SH) has received the approval notice for drug clinical trials.

On April 8th, AIRDOC-B (02251) spent approximately HKD 67,100 to repurchase 6200 shares.

Pagoda GP spent around HK$4.6894 million to repurchase 2.5 million shares on April 8th.

Ze Jing Pharmaceuticals (688266.SH) has received the approval notice for drug clinical trials.

On April 8th, AIRDOC-B (02251) spent approximately HKD 67,100 to repurchase 6200 shares.